10-102133115-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015062.5(PPRC1):c.47G>A(p.Ser16Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,246,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015062.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPRC1 | NM_015062.5 | c.47G>A | p.Ser16Asn | missense_variant | 1/14 | ENST00000278070.7 | NP_055877.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPRC1 | ENST00000278070.7 | c.47G>A | p.Ser16Asn | missense_variant | 1/14 | 1 | NM_015062.5 | ENSP00000278070 | P2 | |
PPRC1 | ENST00000413464.6 | c.47G>A | p.Ser16Asn | missense_variant | 1/12 | 2 | ENSP00000399743 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152238Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000101 AC: 11AN: 1094140Hom.: 0 Cov.: 31 AF XY: 0.0000116 AC XY: 6AN XY: 516880
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.47G>A (p.S16N) alteration is located in exon 1 (coding exon 1) of the PPRC1 gene. This alteration results from a G to A substitution at nucleotide position 47, causing the serine (S) at amino acid position 16 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at